autoantibodies in the SLE patients' serum. There is evidence for polyclonal B cell activation underlying false positive serology for HIV in SLE as well. It was observed that antibodies cross-reactive to HIV p24 gag protein could be found in SLE patients' serum. Indeed, antibodies directed against HLA-DRmolecules (anMHC classIIreceptor) have beenreported to be present in SLE patients' serum, and there is significant sequence homology between MHC class II receptors and HIV antigens, which may explain the aforementioned cross-reactivity. Similarly, the false positive results on Borrelia ELISAs have been suggested to be due to either the non-specific binding of SLE immune complexes to microtitre wells, or the non-specific cross-reactivity of autoantibodies found in SLE to Borrelia antigens (either cytoplasmic or nuclear, or both) in microtitre wells. Alternative explanations have been proposed, which speculate on the presence of other infections that may result in the production of crossreactive antibodies. For example, false positive CMV serology in the context of SLE has been postulated to be due to the presence of another infection, e.g. Epstein-Barr virus (EBV), which might be able to result in a polyclonal B cell reaction. Thus, anti-CMV antibodies may be produced, thereby giving false positive reactions. Antibodies directed against other herpes viruses also appear to show significant cross-reactivity, which could potentially explain CMV false positive serologyin individuals suffering from other herpes infections. Similarly, false positive HIV serology in SLE patients has been proposed to be linked to a possible role for retroviruses in the pathogenesis of SLE. HIV is considered unlikely to be the retrovirus in question but, due to significant homology between retroviruses, it is likely that an SLE sufferer who might have an associated retroviral infection would possess antibodies against the aforementioned retrovirus that would also be cross-reactive to HIV antigens. To conclude, there was a delay in this patient receiving immunotherapy for her lifethreatening cerebral lupus because of a failure to recognise that positive serology results for both CMV and mumps might be false positive, as subsequently confirmed when PCR analysis was performed. False positive CMV serology has been previously reported in SLE, and the possible mechanisms underlying this phenomenon were discussed above. False positive mumps seroreactivity in SLE patients, on the other hand, has so far not been reported in the literature. However, given the non-specific polyclonal nature of the B lymphocyte response induced by SLE and the diversity of autoantibodies found in SLE, it is possible that SLE patients may possess a number of antibodies capable of cross-reacting with mumps antigens, thereby resulting in false positive results on mumps serology tests. It is important for clinicians to recognise the possibility of false viral serology in people with lupus to avoid unnecessary delays in administering immunotherapy. Introduction: Takayasu arteritis is a well-known, yet rare form of large vessel vasculitis with predominance in countries such as India and Japan. It is usually detected in young females aged 20-40, with the most common manifestation of claudication pain and fever of unknown origin. Neurological manifestations are common but rarely present as the first presenting symptom. The reported incidence of neurological manifestations including headache, dizziness, visual disturbance or loss of consciousness, stroke, and transient ischemic attack (TIA) varies from 57% up to 80%. Vasculitis can manifest primarily with striking leptomeningeal involvement as shown in various case reports of ANCA-associated vasculitis and primary CNS angitis. As Takayasu arteritis primarily affects proximal large vessels, leptomeningeal involvement seems theoretically unusual.Here,wereport acaseofnodular leptomeningitisas apresenting manifestation of Takayasu arteritis. Case description: This is a case of a 23 year old female without any prior comorbidity who developed high-grade fever associated with headache and diffuse body ache in September 2017. Fever was not associated with sore throat, cough, burning micturition, altered bowel habits, night sweats or any other localising signs. She was started on azithromycin along with anti-pyretic, but continued to have daily spikes of fever. On the fifth day of illness, she developed altered sensorium. It was not preceded by excruciating headache or vomiting. It was not associated with seizure, arm/leg weakness or abnormal moments. She was taken to a higher centre where on examination she was found to have elevated blood pressure [210/150 mmHg]. She was started on intravenous antihypertensives and in view of altered sensorium; she underwent contrast enhanced computed tomography of the brain, which revealed hydrocephalus with dilated lateral and third ventricle and leptomeningeal enhancement.Shewasreferredtoatertiary carecentre forfurtherevaluation and management. She was brought to the emergency department of our hospital on fifth day of illness. She was febrile and had elevated BP [200/110 mmHg] at time of admission despite being on intravenous antihypertensives. Her GCS was 6/15. Her general examination was unremarkable and respiratory and cardiovascular system examinations were normal. Neurological examination did not show any particular abnormality except bilateral extensor plantar response. She underwent MRI with contrast which showed nodular leptomeningeal enhancement in bilateral front parietal, occipital and right posterior temporal region. There were nodular enhancing foci in cerebellum, thalami, pons and midbrain. Fourth ventricle was compressed with resultant hydrocephalus and there was transtentorial herniationof left cerebellar hemisphere. Further historytaking revealed history of pulmonary tuberculosis in a grandfather four months prior. Based on MRI findings and family history of tuberculosis exposure, probable diagnosis of tubercular meningitis was considered. She was intubated in view of deteriorating sensorium and was started on intravenous antibiotics (ceftriaxone 2 gms twice daily) and anti tubercular treatment (isoniazid, rifampicin, pyrizinamide, ethambutol and levofloxacin). In view of significant brain oedema and diagnosis of tubercular meningitis, intravenous steroids (dexamethasone 8 mg thrice daily) were added as well. She underwent external ventricular drainage procedure to relieve the hydrocephalus. Her drain showed clear cerebrospinal fluid which on cytological, biochemical and microbiological analysis did not reveal any significant abnormality (no evidence of mycobacterium tuberculosis). Her blood investigations revealed low Hb [8.6 gm/dl] and moderately elevated ESR and CRP [45 mm/hr and 36 mg/L]. Her Liver function, renal function, blood culture and urine cultures were sterile and 2 D echo was normal. At this point of time we were dealing with a case consisting of two cardinal issues: fever with altered sensorium for which possible explanation was tubercular leptomeningitis with obstructive hydrocephalus and accelerated hypertension in a young female. Rheumatology review was done in view of nodular enhancement in the brain with suspicion of neurosarcoidosis. After 48 hours of treatment, patient had improvement in sensorium and was extubated. This enabled us to take detailed history from patient herself. Patient said to be having on and off arthralgia and claudication pain in right upper limb for last one month. On re-examination, she was found to be having difference in pulse volume and blood pressure in both upper limbs. To substantiate the diagnosis of tubercular meningitis, repeat cerebrospinal fluid analysis was done which was normal. Her ANA, ENA, ANCA serology and RF were negative. Her serum ACE levels were normal. She was subjected to renal doppler as a part of evaluation of young hypertensive, which revealed left renal artery stenosis. She underwent contrast enhanced computed tomography of chest and abdomen with angiogram of abdominal aorta. It revealed wall thickening with luminal irregularity of infra renal aorta and right subclavian vessels. There was complete occlusion of proximal superior mesenteric artery, left renal artery and right external iliac artery along with small left kidney. Overall findings were suggestive of aortoarteritis. Meanwhile she kept on improving clinically due to intravenous steroids. Her external ventricular drain was removed and her blood pressure was controlled on a combination anti-hypertensive agents. She was switched to oral prednisolone 1 mg/kg.Her previous twoCSFsamples were taken fromventricular drains which were normal. To prove our diagnosis of tubercular meningitis, she was subjected to lumbar puncture and subsequent CSF analysis for the third time which was again normal. As her thrice repeated CSF samples were entirely normal, we became skeptical regarding our diagnosis of tubercular meningitis. But we were unable to explain nodular leptomeningitis and hydrocephalus with diagnosis of Takayasu arteritis alone. In literature review, we could not find any case describing leptomeningitis in patient with Takayasu arteritis. But we found case reports describing leptomeningitis in primary CNS angitis and ANCA-associated vasculitis. Case reports describing nodular enhancement in systemic lupus erythrematous, antiphospholipid syndrome and Behc¸et's disease were also found in the literature. In anticipation of reaching adiagnosis, we repeated MRI brain with MR angiogram of head & neck on day ten of admission. It revealed complete resolution of previously seen nodular lesions, significant decrease in oedema and mass effect, resolution of hydrocephalus and significantly narrowed bilateral middle cerebral artery and intracranial internal carotid artery. A mere course of ten days of anti tubercular treatment did not justify such a rapid resolution of nodular leptomeningitis. This enabled us to rule out coexistent tubercular meningitis. Anti tubercular therapy was discontinued. Based on adequate evidence of nodular leptomeningitis occurring in various forms vasculitis and intracranial vessel involvement well characterised in aortoarteritis patients presenting with neurological symptoms, a final diagnosis was Takayasu arteritis (type V) with nodular leptomeningitis with obstructive hydrocephalus was made. Patient was continued on tapering dose of oral steroid andsteroidsparingimmunosuppressantintheformof methotrexate was started on out patient visit. Patient has received regular followups in the last eight months and is doing well. Discussion: In Takayasu arteritis, involvement of carotid and vertebral arteries cause decreased cerebral blood flow and may present with symptoms ranging from light giddiness to stroke. While the extracranial neurovascular manifestations of Takayasu arteritis are well established, little is known regarding the intracranial manifestations. Intracranial vascular abnormalities in patients of Takayasu arteritis presenting with neurologic symptom are not rare and have been described in 15-20% patients presenting with neurological symptoms. Our patient had intracranial vessel involvement in form of bilateral middle cerebral and intracranial internal carotid artery narrowing. Leptomeningeal enhancement has been described in patients with primary CNS angitis and ANCAassociated vasculitis. Nodular brain lesions have been described in cerebral vasculitis secondary to SLE, anti phospholipid syndrome and Behcet disease. In our case, nodular leptomeningitis may represent diffuse inflammation and vasculitis of intracranial vessels in the cortex and deep white matter. Hydrocephalus in this case could be secondary to posterior fossa oedema caused hypertensive posterior reversible encephalopathy syndrome. In country with high prevalence of tuberculosis, tubercular meningitis remains the most common cause of leptomeningitis with hydrocephalus. But CSF abnormalities are present in almost all cases of tubercular leptomeningitis. Our case had normal CSF on three occasions and she had dramatic response to treatment in the form of resolution of nodular lesions on day ten of illness. Such dramatic resolution could only be due to the steroid therapy she was receiving rather than anti tubercular drugs. This supported Takayasu arteritis as primary diagnosis in our patient and presence of nodular leptomeningitis was thought to be secondary to intracranial vesselinvolvement. Key Learning Points: Though involvement of proximal extra cranial vessels are more common in Takayasu arteritis, it may present with intracranial vascular involvement. Apart from ischemic manifestations, intra cranial vasculitis may manifest as leptomeningeal enhancement and nodular intracranial lesions. Acceleratedhypertension mayleadto posterior reversible encephalopathy syndrome which may cause posterior fossa oedema and hydrocephalus. In a young female, always examine blood pressurein all fourlimbs and look for renal and abdominal bruit. Histopathology, National Hospital for Neurology and Neurosurgery, London, UNITED KINGDOM Introduction: Primary central nervous system vasculitis is a rare but important disease to consider in a patient who presents with headache, cognitive impairment and neurological deficit in the absence of systemic disease. As rheumatologists central nervous system vasculitis in the context of systemic inflammatory diseases is well recognised however in the absence of systemic disease a high index of suspicion is required to make the correct diagnosis with relevant investigations toexcludemimics. Case description: We present a twenty-nine year old male IT consultant who is normally fit and well with no relevant past medical history. In January 2014hepresented tothe emergencydepartmentwith numbness of the right arm and face with word finding difficulties. This was preceded by a one week history of intermittent severe frontal headaches lasting up to thirty minutes with vomiting. There was no photophobia, neck stiffness or fever. There was no identifiable trigger, no recent travel and he denied recreational drug use. On examination there was no focal neurology identified and the patient was discharged with an urgent outpatient MRI brain. A provisional diagnosis of migraine was made. One week later he represented with apersistentmild headache, vomiting,facialdroopand severe ataxia with drowsiness. He was afebrile with no neck stiffness or photophobia. Examination demonstrated a left sided facial droop, left hemiparesis, sensory loss and left sided neglect. Tone was normal, reflexes symmetrical and brisk with flexor planter responses. He had slow, slurred speech with word finding difficulties. Investigations and results from this admission are summarised in Table 1 . A working diagnosis of demyelinating disease was made and he was treated with intravenousmethylprednisolone (1 g X3) and then commenced on a weaning dose of prednisolone (60 mg OD). Symptoms and signs rapidly improved and he was discharged. Thepatient then left the region and was lost to follow-up but then re-presented with similar symptoms in April 2014 to the Edinburgh Royal Infirmary. A repeat MRI brain confirmed progression of multiple infratentorial T2 white matter lesions and MRA showed no evidence of vasculitis. Lumbar puncture revealed a lymphocytic CSF and protein was elevated at 0.85 g/L. Culture and cytology were negative. CT chest abdomen and pelvis, bone marrow aspirate, PET and gallium scans were all normal. He was retreated with prednisolone 60 mg OD with resolution of symptoms but again was lost to follow-up. The working diagnosis at this time was relapsing remitting steroid-responsive lymphocytic meningoencephalitis. Differentials included primary angiitis of the central nervous system (PACNS) and CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids). Three years later, in June 2017, the patient re-presented with a right retro-orbital headache and confusion. On admission he had left sided hemiparesis and slurred speech. A CT head showed multiple areas of low attenuation consistent with the MRI brain from 2014 with the addition of a possible new right frontal-parietal low attenuation lesion. With the clinical presentation and CT findings the patient was thrombolysed for an acute right total anterior stroke but then became acutely agitated with a decline in GCS from 15 to 6. The patient was intubated,treated for meningoencephalitis and loaded empirically with phenytoin. Salient findings on admission were a normocytic anaemia, lymphopaenia, CRP less than 0.6 mg/dL and ESR 6 mm/ hr. Urine toxicology was negative. Anti-neuronal antibodies and Brucella serology were negative. CSF analysis was again predominantly lymphocytic with a protein of 0.49 g/L. Culture was negative as were oligoclonal bands. MRI showed progression of T2 white matter hyperintensity. MRA showed normal vessels. The appearances were reported to be more suggestive of progressive leukoencephalopathy secondary to toxic/metabolic (including genetic) or mitochondrial disease rather than vasculitis. Electroencephalogram reported right posterior temporal slowing which was non-specific with no epileptiform activity. Neuropsychometry showed a mild degree of anterior and subcortical compromise. In summary this patient had a relapsing, remitting neuroinflammatory syndrome with encephalopathy and focal neurology in the absence of systemic inflammation.The CSFwaspredominantlylymphocyticwithmildly raised protein and progressive white matter changes were present on MRI. These episodes were acutely steroid responsive with resolution of neurology. Differentials included neurosarcoidosis, intravascular lymphoma, PACNS and several rare inherited small vessel and mitochondrial diseases which were subsequently excluded by a normal muscle and skin biopsy. In view of the broad differential the patient had a brain biopsy. Histology showed multifocal perivascular inflammatory changes in the white matter with histiocytes and lymphocytes forming ill-defined nonnecrotising granulomatous structures with no evidence of fibrinoid necrosis or vessel wall disruption. The mild leptomeningeal component compared to more severe white matter involvement made a diagnosis of neurosarcoidosis less likely. Microorganisms were not identified and there were no signs of underlying malignancy. Features were in keeping with perivascular inflammation with granulomata, suggestive of primary angiitis of the central nervous system (PACNS). The patient was treated with a tapering dose of prednisolone and cyclophosphamide, as per the European Vasculitis Society guidelines 2009 for remission induction. For maintenance therapy he has been prescribed mycophenolate mofetil. There has been resolution of neurology and no further relapses reported to date. The patient is working full time and back to full physical health. Discussion: The clinical presentation, laboratory findings, imaging, skin and muscle histology were inconclusive in providing a diagnosis. Subjecting the patient to strong immunosuppressive therapy without having a definitive diagnosis led the team to persist in gaining histology from the primary lesion, the brain. Brain histology provided the evidence needed to make the right diagnosis. This is an interesting case as brain biopsy is the gold standard for the diagnosis of PACNS but rarely performed. The range of investigations show how we arrived at the diagnosis and how the mimics of this disease were excluded during this process. We have learnt the different ways PACNS can present and more importantly itsmimics andhowtoinvestigatefortheseinatimely stepwise process. We have learnt how negative results are as important as positive ones when faced with a challenging case. For example the presence of a normal inflammatory response raised the suspicion from the start that this was not a systemic illness. We have also learnt the importance of involving different specialists in challenging cases. In this case the expertise of neurologists, haematologists, infectious diseases and histopathologists were called upon. We have also learnt the different ways PACNS can appear on brain imaging and if the diagnosis is uncertain then brain biopsy should be sought. This case report raises the discussion as to whether, as a speciality, we should be referring more of our patients for brain biopsy when the diagnosis is unclear particularly in those patients who have an absence of systemic disease. Key LearningPoints: The main learningpoints in this case aretoappreciate PACNS is arare disease buthas along list of mimics and some of those will fall under the remit of rheumatology, therefore we should be aware of its presentation and how to investigate in a way that carefully excludes the
